Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan-cancer survey with implications for the use of immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan-cancer survey with implications for the use of immune checkpoint inhibitors

Published:2017-05-31 Issue:8 Volume:56 Page:651-659
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Budczies Jan¹²,Bockmayr Michael¹³,Klauschen Frederick¹²,Endris Volker⁴,Fröhling Stefan²⁵⁶,Schirmacher Peter²⁴,Denkert Carsten¹²,Stenzinger Albrecht²⁴^ORCID

Affiliation:

1. Institute of Pathology, Charité University Hospital; Berlin Germany

2. German Cancer Consortium (DKTK), Partner Sites Berlin and Heidelberg, and German Cancer Research Center (DKFZ); Heidelberg Germany

3. Department of Pediatric Hematology and Oncology; University Medical Center Hamburg-Eppendorf; Hamburg Germany

4. Institute of Pathology, University Hospital Heidelberg; Heidelberg Germany

5. Department of Translational Oncology; National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ); Heidelberg Germany

6. Section for Personalized Oncology, Heidelberg University Hospital; Heidelberg Germany

Funder

German Cancer Consortium (DKTK), Germany

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/gcc.22468/fullpdf

Reference50 articles.

1. The future of immune checkpoint therapy;Sharma;Science

2. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential;Sharma;Cell,2015b